APA (7th ed.) Citation

Aljubran, A., Badran, A., Alrowaily, M., Raef, H., Alzahrani, A. M., Almuhaideb, A., . . . Bazarbashi, S. (2024). Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors. Cancer Biotherapy & Radiopharmaceuticals, 39(2), 164. https://doi.org/10.1089/cbr.2022.0043

Chicago Style (17th ed.) Citation

Aljubran, Ali, et al. "Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors." Cancer Biotherapy & Radiopharmaceuticals 39, no. 2 (2024): 164. https://doi.org/10.1089/cbr.2022.0043.

MLA (9th ed.) Citation

Aljubran, Ali, et al. "Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors." Cancer Biotherapy & Radiopharmaceuticals, vol. 39, no. 2, 2024, p. 164, https://doi.org/10.1089/cbr.2022.0043.